Abstract
A targeted vaccination programme for pandemic H1N1 2009 influenza was introduced in Scotland, UK, in October, 2009. We sought to assess the effectiveness of this vaccine in a sample of the Scottish population during the 2009–10 pandemic.
Methods
We assessed the effectiveness of the Scottish pandemic H1N1 2009 influenza vaccination with a retrospective cohort design. We linked data of patient-level primary care, hospital records, death certification, and virological swabs to construct our cohort. We estimated vaccine effectiveness in a nationally representative sample of the Scottish population by establishing the risk of hospital admission and death (adjusted for potential confounders) resulting from influenza-related morbidity in vaccinated and unvaccinated patients and laboratory-confirmed cases of influenza H1N1 2009 in a subset of patients.
Findings
Pandemic H1N1 2009 influenza vaccination began in week 43 of 2009 (Oct 21, 2009) and was given to 38¿296 (15·5%, 95% CI 15·4–15·6) of 247¿178 people by the end of the study period (Jan 31, 2010). 208¿882 (85%) people were unvaccinated. There were 5207 emergency hospital admissions and 579 deaths in the unvaccinated population and 924 hospital admissions and 71 deaths in the vaccinated population during 23¿893¿359 person-days of observation. The effectiveness of H1N1 vaccination for prevention of emergency hospital admissions from influenza-related disorders was 19·5% (95% CI 0·8–34·7). The vaccine's effectiveness in preventing laboratory-confirmed influenza was 77·0% (95% CI 2·0–95·0).
Interpretation
Pandemic H1N1 2009 influenza vaccination was associated with protection against pandemic influenza and a reduction in hospital admissions from influenza-related disorders in Scotland during the 2009–10 pandemic.
Funding
National Institute for Health Research Health Technology Assessment Programme (UK).
| Original language | English |
|---|---|
| Pages (from-to) | 696-702 |
| Number of pages | 7 |
| Journal | Lancet Infectious Diseases |
| Volume | 12 |
| Issue number | 9 |
| Early online date | 25 Jun 2012 |
| DOIs | |
| Publication status | Published - Sep 2012 |
Fingerprint
Keywords
- H1N1
- pandemic influenza
- vaccine effectiveness
- data linkage
Cite this
Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK : a retrospective observational cohort study. / Simpson, Colin; Ritchie, Lewis Duthie; Robertson, Chris; Sheikh, Aziz; McMenamin, Jim.
In: Lancet Infectious Diseases, Vol. 12, No. 9, 09.2012, p. 696-702.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK
T2 - a retrospective observational cohort study
AU - Simpson, Colin
AU - Ritchie, Lewis Duthie
AU - Robertson, Chris
AU - Sheikh, Aziz
AU - McMenamin, Jim
PY - 2012/9
Y1 - 2012/9
N2 - Background A targeted vaccination programme for pandemic H1N1 2009 influenza was introduced in Scotland, UK, in October, 2009. We sought to assess the effectiveness of this vaccine in a sample of the Scottish population during the 2009–10 pandemic. Methods We assessed the effectiveness of the Scottish pandemic H1N1 2009 influenza vaccination with a retrospective cohort design. We linked data of patient-level primary care, hospital records, death certification, and virological swabs to construct our cohort. We estimated vaccine effectiveness in a nationally representative sample of the Scottish population by establishing the risk of hospital admission and death (adjusted for potential confounders) resulting from influenza-related morbidity in vaccinated and unvaccinated patients and laboratory-confirmed cases of influenza H1N1 2009 in a subset of patients. Findings Pandemic H1N1 2009 influenza vaccination began in week 43 of 2009 (Oct 21, 2009) and was given to 38¿296 (15·5%, 95% CI 15·4–15·6) of 247¿178 people by the end of the study period (Jan 31, 2010). 208¿882 (85%) people were unvaccinated. There were 5207 emergency hospital admissions and 579 deaths in the unvaccinated population and 924 hospital admissions and 71 deaths in the vaccinated population during 23¿893¿359 person-days of observation. The effectiveness of H1N1 vaccination for prevention of emergency hospital admissions from influenza-related disorders was 19·5% (95% CI 0·8–34·7). The vaccine's effectiveness in preventing laboratory-confirmed influenza was 77·0% (95% CI 2·0–95·0). Interpretation Pandemic H1N1 2009 influenza vaccination was associated with protection against pandemic influenza and a reduction in hospital admissions from influenza-related disorders in Scotland during the 2009–10 pandemic. Funding National Institute for Health Research Health Technology Assessment Programme (UK).
AB - Background A targeted vaccination programme for pandemic H1N1 2009 influenza was introduced in Scotland, UK, in October, 2009. We sought to assess the effectiveness of this vaccine in a sample of the Scottish population during the 2009–10 pandemic. Methods We assessed the effectiveness of the Scottish pandemic H1N1 2009 influenza vaccination with a retrospective cohort design. We linked data of patient-level primary care, hospital records, death certification, and virological swabs to construct our cohort. We estimated vaccine effectiveness in a nationally representative sample of the Scottish population by establishing the risk of hospital admission and death (adjusted for potential confounders) resulting from influenza-related morbidity in vaccinated and unvaccinated patients and laboratory-confirmed cases of influenza H1N1 2009 in a subset of patients. Findings Pandemic H1N1 2009 influenza vaccination began in week 43 of 2009 (Oct 21, 2009) and was given to 38¿296 (15·5%, 95% CI 15·4–15·6) of 247¿178 people by the end of the study period (Jan 31, 2010). 208¿882 (85%) people were unvaccinated. There were 5207 emergency hospital admissions and 579 deaths in the unvaccinated population and 924 hospital admissions and 71 deaths in the vaccinated population during 23¿893¿359 person-days of observation. The effectiveness of H1N1 vaccination for prevention of emergency hospital admissions from influenza-related disorders was 19·5% (95% CI 0·8–34·7). The vaccine's effectiveness in preventing laboratory-confirmed influenza was 77·0% (95% CI 2·0–95·0). Interpretation Pandemic H1N1 2009 influenza vaccination was associated with protection against pandemic influenza and a reduction in hospital admissions from influenza-related disorders in Scotland during the 2009–10 pandemic. Funding National Institute for Health Research Health Technology Assessment Programme (UK).
KW - H1N1
KW - pandemic influenza
KW - vaccine effectiveness
KW - data linkage
U2 - 10.1016/S1473-3099(12)70133-0
DO - 10.1016/S1473-3099(12)70133-0
M3 - Article
VL - 12
SP - 696
EP - 702
JO - Lancet Infectious Diseases
JF - Lancet Infectious Diseases
SN - 1473-3099
IS - 9
ER -